Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.32
+0.02
(+0.87%)
USD |
NASDAQ |
Nov 10, 10:07
Bridgebio Oncology Therapeutics Cash and Short Term Investments (Quarterly) : 225.71M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 225.71M |
| March 31, 2026 | 252.28M |
| December 31, 2025 | 425.46M |
| September 30, 2025 | 468.28M |
| June 30, 2025 | 0.6642M |
| March 31, 2025 | 0.9631M |
| Date | Value |
|---|---|
| December 31, 2024 | 155.63M |
| September 30, 2024 | 1.786M |
| June 30, 2024 | 1.814M |
| March 31, 2024 | 1.844M |
| December 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 456.22M |
| IRulya Therapeutics, Inc. | 115.98M |
| PepGen Inc. | 117.24M |
| Q32 Bio, Inc. | 289.59M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |